Biocan DHPPi+L Liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań
Biocan DHPPi+L Liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań
Authorised
- Canine distemper virus, strain CDVU 39, Live
- Canine adenovirus 2, strain CAV-2-Bio 13, Live
- Canine parvovirus, strain OP-I/81, Live
- Canine parainfluenza virus 2, strain CPiV-2-Bio 15, Live
- Leptospira kirschneri, Serogroup Grippotyphosa, Inactivated
Product identification
Medicine name:
Biocan DHPPi+L Liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań
Active substance:
- Canine distemper virus, strain CDVU 39, Live
- Canine adenovirus 2, strain CAV-2-Bio 13, Live
- Canine parvovirus, strain OP-I/81, Live
- Canine parainfluenza virus 2, strain CPiV-2-Bio 15, Live
- Leptospira kirschneri, Serogroup Grippotyphosa, Inactivated
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine distemper virus, strain CDVU 39, Live31622.80/tissue culture infective dose 501.00millilitre(s)
-
Canine adenovirus 2, strain CAV-2-Bio 13, Live31622.80/tissue culture infective dose 501.00millilitre(s)
-
Canine parvovirus, strain OP-I/81, Live316228.00/tissue culture infective dose 501.00millilitre(s)
-
Canine parainfluenza virus 2, strain CPiV-2-Bio 15, Live15848.90/tissue culture infective dose 501.00millilitre(s)
-
Leptospira kirschneri, Serogroup Grippotyphosa, Inactivated
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog
-
No data provided
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AI02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Grabikowski-Grabikowska Przedsiębiorstwo Produkcyjno-Handlowo-Usługowe INEX Sp. j.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 2010
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
How useful was this page?:
